These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 17481561
1. The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells. Shen HW, Chen YL, Chern CY, Kan WM. Prostaglandins Other Lipid Mediat; 2007 May; 83(3):231-6. PubMed ID: 17481561 [Abstract] [Full Text] [Related]
2. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent. Lau AH, Lai HK, Yeung BH, Leung SL, Tsang SY, Wong YH, Wise H. Prostaglandins Leukot Essent Fatty Acids; 2012 Mar; 86(3):119-26. PubMed ID: 22336225 [Abstract] [Full Text] [Related]
3. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF. Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554 [Abstract] [Full Text] [Related]
4. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Beneytout JL, Nappez C, Leboutet MJ, Malinvaud G. Biochem Biophys Res Commun; 1995 Feb 06; 207(1):398-404. PubMed ID: 7857294 [Abstract] [Full Text] [Related]
5. Oncoprotein 18 levels and phosphorylation mediate megakaryocyte polyploidization in human erythroleukemia cells. Chang CL, Hora N, Huberman N, Hinderer R, Kukuruga M, Hanash SM. Proteomics; 2001 Nov 06; 1(11):1415-23. PubMed ID: 11922601 [Abstract] [Full Text] [Related]
6. Protein content and number of nucleolar organizer regions are enhanced during phorbol ester-induced differentiation of cultured human megakaryocytic cells. Baatout S, Chatelain B, Staquet P, Symann M, Chatelain C. Anticancer Res; 1999 Nov 06; 19(4B):3229-35. PubMed ID: 10652616 [Abstract] [Full Text] [Related]
7. Induction of prostacyclin receptor expression in human erythroleukemia cells. Murray R, Furci L, FitzGerald GA. FEBS Lett; 1989 Sep 11; 255(1):172-4. PubMed ID: 2477277 [Abstract] [Full Text] [Related]
8. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells. Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW. Platelets; 2007 Dec 11; 18(8):566-78. PubMed ID: 18041647 [Abstract] [Full Text] [Related]
9. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent. Sato S, Tomoyasu S, Okabe-Kado J, Hozumi M, Tsuruoka N, Nakai S, Adachi M, Honma Y. Exp Hematol; 1996 Jan 11; 24(1):37-42. PubMed ID: 8536790 [Abstract] [Full Text] [Related]
10. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells. Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A. Ann Hematol; 2009 Oct 11; 88(10):989-97. PubMed ID: 19241077 [Abstract] [Full Text] [Related]
11. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells. Wilson SM, Shen P, Rider CF, Traves SL, Proud D, Newton R, Giembycz MA. J Immunol; 2009 Nov 15; 183(10):6788-99. PubMed ID: 19880449 [Abstract] [Full Text] [Related]
12. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Mori A, Saito M, Sakamoto K, Narita M, Nakahara T, Ishii K. Eur J Pharmacol; 2007 Sep 10; 570(1-3):135-41. PubMed ID: 17628525 [Abstract] [Full Text] [Related]
13. Regulation of megakaryocyte phenotype in human erythroleukemia cells. Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. J Clin Invest; 1990 Apr 10; 85(4):1072-84. PubMed ID: 2318965 [Abstract] [Full Text] [Related]
14. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Seiler SM, Brassard CL, Federici ME, Romine J, Meanwell NA. Prostaglandins; 1997 Jan 10; 53(1):21-35. PubMed ID: 9068064 [Abstract] [Full Text] [Related]
15. Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon. Rudd JA, Qian Ym, Tsui KK, Jones RL. Br J Pharmacol; 2000 Feb 10; 129(4):782-90. PubMed ID: 10683203 [Abstract] [Full Text] [Related]
16. Phorbol ester-induced down-regulation of topoisomerase II alpha mRNA in a human erythroleukemia cell line. Evidence for a post-transcriptional mechanism. Loflin PT, Altschuler E, Hochhauser D, Hickson ID, Zwelling LA. Biochem Pharmacol; 1996 Oct 11; 52(7):1065-72. PubMed ID: 8831726 [Abstract] [Full Text] [Related]
17. A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation. Cailleteau C, Liagre B, Beneytout JL. J Cell Biochem; 2009 Jul 01; 107(4):785-96. PubMed ID: 19415684 [Abstract] [Full Text] [Related]
18. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells. Cailleteau C, Liagre B, Battu S, Jayat-Vignoles C, Beneytout JL. Anal Biochem; 2008 Sep 01; 380(1):26-34. PubMed ID: 18549804 [Abstract] [Full Text] [Related]
19. [Combination of thymidine and dexamethasone increases the K562 tumor cells sensitivity to human leukocytes cytotoxicity]. Anisimov AG, Chekmasova AA, Volkova TO, Nemova NN. Tsitologiia; 2001 Sep 01; 43(1):76-81. PubMed ID: 11392818 [Abstract] [Full Text] [Related]